Effects of CD70 and CD11a in Immune Thrombocytopenia Patients

Overview

Journal J Clin Immunol

Publisher Springer

Specialty Allergy & Immunology

Date 2011 May 5

PMID 21541792

Citations 1

Authors

Li Ma

Zeping Zhou

Hairong Jia

Hu Zhou

Aiping Qi

Huiyuan Li

Hongmei Wang

Lei Zhang

Renchi Yang

Affiliations

Soon will be listed here.

Abstract

Introduction: CD70 and CD11a are co-stimulatory molecules that are important for the immune functions of T, B lymphocytes. Over-expressions of CD70 or CD11a cause T cell to be autoreactive.

Objectives: The purpose of this study was to explore the effect of CD70 and CD11a in immune thrombocytopenia (ITP).

Methods: CD70 and CD11a mRNAs and protein expressions in CD4(+) T cells from ITP patients were measured respectively by real-time quantitative-PCR (RT-PCR) and flow cytometry. The apoptosis of T cells, B cells, and platelets in the PBMCs were analyzed by flow cytometry, and secretion of IL-4, IFN-γ, as well as IgG in the reaction supernatant were detected by ELISA. In order to investigate the effects of CD70 and CD11a over-expression on pathogenesis of ITP, anti-CD70, and anti-CD11a mAbs were used to block the signaling pathways.

Results: CD70 and CD11a mRNAs and protein expressions in CD4(+) T cells from ITP patients were significantly higher than healthy controls. In vitro co-culturing of PBMCs with anti-CD70 or anti-CD11a, the apoptosis of T, B lymphocytes were significantly increased but apoptosis of platelets were reduced. Anti-CD11a and anti-CD70 both significantly suppressed the secretion of IFN-γ, while anti-CD11a significantly promoted the secretion of IL-4. There was no significant difference in the healthy group.

Conclusions: CD70 and CD11a facilitate the survival of T, B lymphocytes and indirectly enhance the destruction of platelets in ITP. Blockade of CD70 or CD11a are promising therapeutic approaches for ITP.

Citing Articles

Expression of CD11a in lymphocyte subpopulation in immune thrombocytopenia.

Liu Y, Zhang F, Yao Q, Yuan T, Xu J, Zhu X Int J Clin Exp Pathol. 2016; 8(12):15642-51.

PMID: 26884833 PMC: 4730046.

References

McMillan R . The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura. Semin Hematol. 2000; 37(1 Suppl 1):5-9. DOI: 10.1016/s0037-1963(00)90111-2. View

Yamada A, Salama A, Sho M, Najafian N, Ito T, Forman J . CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J Immunol. 2005; 174(3):1357-64. DOI: 10.4049/jimmunol.174.3.1357. View

Dolfi D, Boesteanu A, Petrovas C, Xia D, Butz E, Katsikis P . Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells. J Immunol. 2008; 180(5):2912-21. PMC: 2931327. DOI: 10.4049/jimmunol.180.5.2912. View

Nolte M, van Olffen R, van Gisbergen K, van Lier R . Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev. 2009; 229(1):216-31. DOI: 10.1111/j.1600-065X.2009.00774.x. View

Xingyuan M, Wenyun Z, Tianwen W . Leukocyte function-associated antigen-1: structure, function and application prospects. Protein Pept Lett. 2006; 13(4):397-400. DOI: 10.2174/092986606775974429. View

Panitsas F, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou G, Zoumbos N . Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood. 2003; 103(7):2645-7. DOI: 10.1182/blood-2003-07-2268. View

Olsson B, Andersson P, Jernas M, Jacobsson S, Carlsson B, Carlsson L . T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003; 9(9):1123-4. DOI: 10.1038/nm921. View

Richardson B, Powers D, HOOPER F, Yung R, ORourke K . Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum. 1994; 37(9):1363-72. DOI: 10.1002/art.1780370915. View

Oflazoglu E, Boursalian T, Zeng W, Edwards A, Duniho S, McEarchern J . Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis. J Immunol. 2009; 183(6):3770-7. DOI: 10.4049/jimmunol.0901637. View

10.

Maurer D, Holter W, Majdic O, Fischer G, Knapp W . CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol. 1990; 20(12):2679-84. DOI: 10.1002/eji.1830201223. View

11.

Ochsenbein A, Riddell S, Brown M, Corey L, Baerlocher G, Lansdorp P . CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. J Exp Med. 2004; 200(11):1407-17. PMC: 2211945. DOI: 10.1084/jem.20040717. View

12.

van Seventer G, Shimizu Y, Horgan K, Shaw S . The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol. 1990; 144(12):4579-86. View

13.

van Oosterwijk M, Juwana H, Arens R, Tesselaar K, van Oers M, Eldering E . CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development. Int Immunol. 2007; 19(6):713-8. DOI: 10.1093/intimm/dxm033. View

14.

Kaplan M, Beretta L, Yung R, Richardson B . LFA-1 overexpression and T cell autoreactivity: mechanisms. Immunol Invest. 2000; 29(4):427-42. View

15.

Koopman G, Reutelingsperger C, Kuijten G, Keehnen R, Pals S, van Oers M . Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994; 84(5):1415-20. View

16.

Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H . High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 2003; 71(4):283-8. DOI: 10.1034/j.1600-0609.2003.00138.x. View

17.

van Lier R, Borst J, Vroom T, Klein H, van Mourik P, Zeijlemaker W . Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol. 1987; 139(5):1589-96. View

18.

Tohma S, Ramberg J, Lipsky P . Expression and distribution of CD11a/CD18 and CD54 during human T cell-B cell interactions. J Leukoc Biol. 1992; 52(1):97-103. DOI: 10.1002/jlb.52.1.97. View

19.

Arens R, Schepers K, Nolte M, van Oosterwijk M, van Lier R, Schumacher T . Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J Exp Med. 2004; 199(11):1595-605. PMC: 2211777. DOI: 10.1084/jem.20031111. View

20.

Provan D, Stasi R, Newland A, Blanchette V, Bolton-Maggs P, Bussel J . International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2009; 115(2):168-86. DOI: 10.1182/blood-2009-06-225565. View